Top Month

Flat Medical Announces Key U.S. Leadership Appointments

PITTSBURGH,PA.,March 11,2025-- Flat Medical announces strategic additions and promotions to its U.S. executive leadership team,positioning the company for continued growth in the North American medica

Top Month

Mar 12, 2025

Meliá Ho Tram Beach Resort Unveils Your All-Inclusive Beachfront Experience in Vietnam

HO TRAM,Vietnam,March 12,2025-- Nestled along Vietnam\'s stunning southern coastline,Meliá Ho Tram Beach Resort offers an effortless blend of luxury,natural beauty,and world-class hospitality.

Top Month

Mar 12, 2025

Vietnamese Party General Secretary - H.E. To Lam and Vietnam - Indonesia high-level delegation witness strategic partnership signing between TTC AgriS and Sungai Budi Group

JAKARTA,Indonesia,March 12,2025-- Under the witness of Vietnamese Party General Secretary - H.E. To Lam and Senior Ministers from both nations,on March 10th,TTC AgriS (Thanh Thanh Cong – Bien Hoa Joi

Top Month

Mar 12, 2025

BeLive Revolutionises Live Video with AI-Powered Suite

SINGAPORE,March 12,2025--BeLive,an innovator in live video technology,today announced the launch of its suite of AI-powered products,designed to transform how businesses and creators engage with their

Top Month

Mar 12, 2025

Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH

RAICHUR,India,March 12,2025--Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED),a leading API and formulation manufacturer,announces that the Subject Expert Committee (SEC) of CDSCO has approved

Top Month

Mar 12, 2025

U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®

OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating compar

Top Month

Mar 11, 2025

1 ... 40 41 42 43 44 45 46 ... 122